ATP5MK and depressive symptom measurement: Emerging evidence suggests that autoimmune disorders, including Hashimoto’s thyroiditis and rheumatoid arthritis, may modulate AGP concentrations, potentially confounding the observed association between AGP and depression [40, 41].